Evidence Based Medical Educator Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Regeneron Pharmaceuticals2 trials
• Amgen1 trial

Running trials

• Active, not recruiting

  Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

  NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source

Closed trials

• Completed

  A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

  NCT05899816· Phase 3· Amgen· Source

• Completed

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Regeneron Pharmaceuticals· Source